Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 6/20 | 0.64 |
| ▸ | NPC1 | O15118 | 5/20 | 0.64 |
| ▸ | RAB9A | P51151 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31068310 | 1.00 | KIF11 (0.66) | KIF11LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2491853 | 0.83 | LMNA (0.66) | LMNANPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL17161297 | 0.82 | LMNA (0.65) | LMNANPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3472841 | 0.81 | HDAC1 (0.63) | LMNANPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL20560335 | 0.81 | NPC1 (0.59) | LMNANPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL29809375 | 0.81 | HDAC1 (0.63) | LMNANPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL30343207 | 0.81 | KIF11 (0.65) | KIF11NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL30499697 | 0.81 | KIF11 (0.51) | KIF11LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2367225 | 0.81 | KIF11 (0.65) | KIF11NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6823604 | 0.81 | KIF11 (0.51) | KIF11LMNANPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151547-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20070265345-A1 | Novel Biphenyl Compounds And Their Use | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265345-A1 | Novel Biphenyl Compounds And Their Use | KIF5B, KIF5C, KIF5A | KIF11 8/4885LMNA 3656/4885NPC1 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.